Antibody Production Market Worth 13.28 Billion USD by 2021

Aug 18, 2016, 07:30 ET from MarketsandMarkets

PUNE, India, August 18, 2016 /PRNewswire/ --

According to a new market research report "Antibody Production Market by Process (Upstream Processing, Downstream Processing, and Filtration), End-User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Research Institutes) - Global Forecast to 2021" published by MarketsandMarkets, This market is expected to reach USD 13.28 Billion by 2021 from USD 7.45 Billion in 2016, at a CAGR of 12.3%.

     (Logo: http://photos.prnewswire.com/prnh/20160303/792302)

Browse 221 market data Tables and 38 Figures spread through 211 Pages and in-depth TOC on "Antibody Production Market"

http://www.marketsandmarkets.com/Market-Reports/antibody-production-market-181543091.html

Early buyers will receive 10% customization on this report. 

This report analyzes and studies the major market drivers, restraints, challenges, and opportunities for the forecast period of 2016 to 2021. A number of factors such as the improved approval rate for therapeutic antibodies by regulatory authorities, patent expiry of blockbuster monoclonal antibodies, increasing adoption of targeted immunotherapy, and increased R&D expenditure of pharmaceutical and biotechnology companies are key drivers for the growth of the Antibody Production Market. Moreover, the increasing risk of infectious diseases and rising demand for protein therapeutics are expected to drive market growth during the forecast period.

In this report, the Antibody Production Market is segmented on the basis of process, end user, and region. Based on process, the Antibody Production Market is categorized into products for upstream processing, downstream processing, and filtration. The downstream processing segment is expected to account for the largest share of the Antibody Production Market in 2016. This segment is also projected to register the highest CAGR during the forecast period.

On the basis of end user, the Antibody Production Market is segmented into pharmaceutical and biotechnology companies, research institutes, and diagnostic laboratories. The pharmaceutical and biotechnology companies segment is expected to account for the largest share of the market in 2016, and is projected to register the highest CAGR during the forecast period.

Geographically, the global Antibody Production Market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (Latin America, Middle East, and Africa). North America is expected to account for the largest share of the Antibody Production Market in 2016, followed by Europe. The Asia-Pacific region offers significant growth opportunities for companies offering antibody production products, and is projected to grow at the highest CAGR during the forecast period.

Speak to our research experts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=181543091

Prominent players in the Antibody Production Market include GE Healthcare (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Pall Corporation (U.S.), Sigma-Aldrich Corporation (Germany), Eppendorf AG (Germany), Cellab GmbH (Germany), INTEGRA Biosciences AG (Switzerland), and FiberCell Systems Inc. (U.S.).

Browse Related Reports: 

Pharmaceutical Filtration Market by Product (Membrane Filters, Single-use systems), Techniques (Ultrafiltration, Cross Flow Filtration), Applications, Scale of Operations, Geography (North America, Europe) - Global Forecast to 2020

http://www.marketsandmarkets.com/Market-Reports/pharmaceutical-filtration-market-209343847.html  
Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type (Bacteria, Yeast), Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers)-Global Forecast to 2019

http://www.marketsandmarkets.com/Market-Reports/single-use-bioreactor-market-49113750.html  
About MarketsandMarkets:

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

SOURCE MarketsandMarkets